2 research outputs found

    Phytochemical composition and antitrypanosomal activities Of aqueous leaf extracts of Loranthus micranthus Linn. (Loranthaceae) in rats infected with Trypanosoma brucei Brucei

    Get PDF
    Phytochemical composition and antitrypanosomal activities of aqueous leaf extracts of Loranthus micranthus in rats infected with Trypanosoma brucei brucei was investigated for 28 days using 72 adult male albino rats weighing between 150 – 250 g. The rats were divided into six groups (A – F), replicated thrice with each replicate having four rats. Group A, B and C were given 400 mg/kg, 800 mg/kg and 1200 mg/kg of the extracts respectively, according to their body weights, while group D, E and F served as the negative, positive and normal control groups, respectively. LD50, phytochemical screening, parasitaemia and body weight were determined using standard methods. It was observed that tannins and flavonoids were highly present, alkaloids, resins, steroids and saponins were moderately present in the plant extract, while terpenes and glycosides were present in trace amounts. LD50 of the crude leaf extract of L. micranthus showed no mortality at dose levels of up to 5,000 mg/kg after 24 hours. The level of parasitaemia in all the tested groups and negative control were significantly high (p<0.05) when compared with the positive and normal control groups throughout the duration of the experiment. Similarly, a significant decrease (p<0.05) was observed in the mean values of body weights of the infected and treated animals throughout the duration of the experiment. The results showed that all the tested rats and negative control groups died from the overwhelming parasitaemia unlike the case of those administered the standard drug. The aqueous leaf extract of L. micranthus may not be used as an antitrypanosomal agent.Keywords: Phytochemical composition, Parasitaemia, Trypanosomiasis, Albino rats, Loranthus micranthus, Non antitrypanosomal agen

    Gene therapy, physiological applications, problems and prospects - a review

    Get PDF
    Gene therapy can be defined as the use of DNA as a pharmaceutical agent to treat disease. It is also an experimental medical treatment that manipulates a gene or genes within cells in order to produce proteins that change the function of those cells. The physiological applications, problems and prospects of gene therapy are reviewed in this study. The different types of gene therapy such as germline gene therapy, somatic gene therapy and chimeraplasty gene therapy are discussed. Polymerase chain reaction (PCR), nanoparticles, sonoporation, electroporation and gene gun are the techniques used in gene therapy. Polymerase chain reaction (PCR) is used in medical and biological research. Nanoparticles have been widely used in the field of drug and gene delivery to target cells. Sonoporation allows uptake of large molecules of DNA into the cell, in a process called cell transformation. Electroporation is highly efficient for the introduction of foreign genes in tissue culture cells, in tumor treatment and cell-based therapy. A gene gun is a device for injecting cells with genetic information to plant cells. Gene therapy is applied in medicine, agriculture, loss and gain of function, tracking and expression studies. Some problems bedeviling gene therapy include insertional mutagenesis, mutagenic disorders, problem of viral vectors, immune response etc. Gene therapy has the potential to eliminate and prevent hereditary diseases such as cystic fibrosis and is a possible cure for Alziehmer’s disease and cancer, enhance agricultural productivity of farm animals, and in the production of genetically modified animals (GMOs) which will further help in medical and biomedical research.Keywords: Gene therapy, Chimeraplasty, Nanoparticles, Sonoporation, Electroporation, Gene gun, Polymerase chain reactio
    corecore